For example, delayed antitumor effects observed in the NOG mouse model (Figure 2E) compared to syngeneic mouse models (Figures 4E, F and G) might be explained by xenogeneic GVHD reaction that might promote late activation and expansion of hCAR-T cells. Here, CXADR is linked to graft versus host disease.